Trump struck deals with 16 drug companies. But they're still raising prices this year - NPR
AI Summary1 min read
TL;DR
Despite deals with 16 drug companies under Trump, prices are still rising this year, highlighting ongoing challenges in U.S. drug pricing and policies like MFN.
- Trump struck deals with 16 drug companies. But they're still raising prices this year NPR
- Prescription drug prices LAist
- Large drugmakers without a US pricing pact are bracing to make one Endpoints News
- Pharma companies bowed to Trump's recent pricing pressure medwatch.com
- US pharma MFN and tariff dynamics: What EU and UK leaders need to know pharmaphorum